Replies to post #426089 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

Hard to disagree!

[bas2020]

I believe part of the reasoning to delay AD to after Rett, in addition to the voucher, is that Anavex knows there'll be considerable "headwinds" with the FDA to consider a "competitive" AD drug that has the potential to annihilate recently approved "friendly" BP MABs.

the AVXL strategy to delay progress on potential AD regulatory approval in order to gamble on Rett EXCELLENCE success with the attendant $100 million voucher, is really negatively impacting AVXL shareholders for the time being.

Glad to know Anavex has a biomarker it can use to checkmate a potential ploy the FDA might try.

[nidan7500]

Sub $7.75 expected by EOD for more reloading

How is what honest AVXL share holders are being subjected to (again) today and different than robbery? Robbery is what it is. These thieves seem to admire themselves as clever liars who can steal at will.

Time to start checking over your shoulders.